BioInteractions Launches Surface-Active Systems – A New Standard in Long Term Medical Device Performance New category of ...

SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced the U.S. Food and Drug Administration (FDA) has granted Accelerated Approval of SKYSONA® (elivaldogene autotemcel) ...

Natural compounds continue to play a key role in drug development. Many clinically approved drugs are either unmodified natural products or their semi-synthetic derivatives. This book series presents ...

Panelists discuss how the GALAXI-2 and GALAXI-3 trials represented a landmark study design for Crohn’s disease research ...

Bristol Myers Squibb Co.’s decision this week to snag Bluebird Bio Inc. spinout 2seventy Bio Inc. for $102 million net – just weeks after investors bid $30 million for Bluebird itself – seemed to ...

All linked products are independently selected by our editors. If you purchase any of these products, we may earn a commission. Despite an abundance of skincare brands at my fingertips, the latter is ...

Buffalo, NY , Oct. 01, 2025 (GLOBE NEWSWIRE) -- POP Biotechnologies, Inc. (POP BIO), has been awarded a $2.46M USD grant by ...

A new technique for harvesting electrochemically active bacteria in their natural environment is paving the way for further study of the microorganisms. A research team from Washington State ...

The regulatory record for successful replacements of the human meniscus is thin, but the latest attempt came up short as a U.S. FDA advisory committee voted 6-2 that the benefits of the Nusurface ...

KCAS is on a growth tear, with two acquisitions this year and a new facility in Olathe. Olathe-based contract research company KCAS Bioanalytical and Biomarker Services expanded its reach in Europe ...